Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 04, 2024, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivosidenib Tablets 250 mg".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 04, 2024, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivosidenib Tablets 250 mg".